For example, researchers will measure cell death to determine a drug’s anticancer effectiveness. Scientists commonly use caspase assays to evaluate apoptosis, evaluating caspase activation—a hallmark ...
Glioblastoma, one of the most aggressive and lethal brain cancers, has a five-year survival rate of only 6.9%, according to the National Brain Tumor Society. While the relationship between ...
Triple-negative breast cancer, an aggressive type of breast cancer, accounts for 10% of all breast cancer cases in the United ...
Researchers have characterised how dying, or necrotic, cells contribute to the body’s regeneration process, with potential implications for wound and tissue repair.
Hoth Therapeutics (HOTH) announced breakthrough preclinical findings demonstrating the efficacy of HT-KIT, a novel targeted ...
Breast cancer is one of the leading causes of mortality among women worldwide. Tumor necrosis factor α-induced protein 3-interacting protein 1 (TNIP1 ...
Global Cell-Based Assays Market size is expected to be worth around US$ 37.1 Billion by 2032 from US$ 17.7 Billion in 2023, growing at a CAGR of 8.8% Drug Discovery Accounted For The Largest ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback